# GO_biological_process_0121

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_biological_process`  
**Author expected answer:** **A** — antibiotic biosynthetic process

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MTDTTLVEAGDPAEDAPEWPMKRDTGCPFDPPPGVRKLLAEKPLSRARIWDGSTPWVVTRHADQRALLSDPRVSHDGLRDGYPHISADFKFLSMAQPSFAGQDDPEHGRIRRMVTLPFTARRIEAMRPAIQKITDELIDGMLAGPKPVDLVEALALPVPVRVICEMLGVPYEDREFLQQNNNAMIYRDTAQGDAQKAAIAQAMYLKELVGTKLGDRGDDILSDLAVQVEAGEITQDDAAGIGMMLLGAGHETTANMIALGTLALLENPEQLAEVRDSDDPKVIVNTVEELLRYLTIAQDTVRRIAAEDIEIGGVVIKAGEGIVFPLNAANWDPDLYPEAPDRLDIHRANARRHLAFGYGVHQCLGATLARVELQIVYSTLLRRIPTLALAGTLDEIPFKHDQIAHGVYELPVTW

[Multiple Choices]
A. antibiotic biosynthetic process
B. killing of cells of another organism
C. protein quality control for misfolded or incompletely synthesized proteins
D. response to antibiotic
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied sequence exactly matches the UniProt GfsF sequence. Its function annotation, supported by cited experimental evidence, says it catalyzes modifications involved in synthesis of the macrolide antibiotics FD-891 and FD-892. This supports antibiotic biosynthesis; the GO association itself is marked IEA.

Citations as saved: [C5](#evidence-c5), [H5](#evidence-h5), [H7](#evidence-h7).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A bacterial P450-like sequence can suggest oxidative enzymatic activity, but that broad inference does not identify its substrate or show that it participates in antibiotic biosynthesis rather than another process.


**Missing item-specific fact**

> The protein-specific identification and functional evidence that GfsF modifies intermediates in FD-891/FD-892 biosynthesis.


**Reason**

> The sequence alone does not provide a defensible basis to distinguish antibiotic biosynthesis from the alternatives. Choosing A requires the protein-specific function, not merely recognition of a general sequence feature.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched protein's experimentally supported role in antibiotic biosynthesis directly supports A; the other options describe different processes.


### Important caveats

- The cited UniProt function annotation has experimental evidence codes, whereas the listed GO annotation is an IEA association; these evidence types should not be conflated.
- The exact author source snapshot is unknown, although the sequence matches both the historical and current UniProt records.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A bacterial P450-like sequence can suggest oxidative enzymatic activity, but that broad inference does not identify its substrate or show that it participates in antibiotic biosynthesis rather than another process.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identification and functional evidence that GfsF modifies intermediates in FD-891/FD-892 biosynthesis.",
    "reason": "The sequence alone does not provide a defensible basis to distinguish antibiotic biosynthesis from the alternatives. Choosing A requires the protein-specific function, not merely recognition of a general sequence feature."
  },
  "case_id": "GO_biological_process_0121",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H5",
      "H7"
    ],
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt GfsF sequence. Its function annotation, supported by cited experimental evidence, says it catalyzes modifications involved in synthesis of the macrolide antibiotics FD-891 and FD-892. This supports antibiotic biosynthesis; the GO association itself is marked IEA."
  },
  "important_caveats": [
    "The cited UniProt function annotation has experimental evidence codes, whereas the listed GO annotation is an IEA association; these evidence types should not be conflated.",
    "The exact author source snapshot is unknown, although the sequence matches both the historical and current UniProt records."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched protein's experimentally supported role in antibiotic biosynthesis directly supports A; the other options describe different processes."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0121",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt GfsF sequence. Its function annotation, supported by cited experimental evidence, says it catalyzes modifications involved in synthesis of the macrolide antibiotics FD-891 and FD-892. This supports antibiotic biosynthesis; the GO association itself is marked IEA.",
    "evidence_ids": ["C5", "H5", "H7"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A bacterial P450-like sequence can suggest oxidative enzymatic activity, but that broad inference does not identify its substrate or show that it participates in antibiotic biosynthesis rather than another process.",
    "missing_item_specific_fact": "The protein-specific identification and functional evidence that GfsF modifies intermediates in FD-891/FD-892 biosynthesis.",
    "reason": "The sequence alone does not provide a defensible basis to distinguish antibiotic biosynthesis from the alternatives. Choosing A requires the protein-specific function, not merely recognition of a general sequence feature."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched protein's experimentally supported role in antibiotic biosynthesis directly supports A; the other options describe different processes."
  },
  "important_caveats": [
    "The cited UniProt function annotation has experimental evidence codes, whereas the listed GO annotation is an IEA association; these evidence types should not be conflated.",
    "The exact author source snapshot is unknown, although the sequence matches both the historical and current UniProt records."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry E0D207 (Cytochrome P450 GfsF from Streptomyces halstedii) is explicitly annotated with GO:0017000 'antibiotic biosynthetic process' (H7). The FUNCTION comment (C5/H5) states it is 'Involved in the synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892,' and the PATHWAY comment (C6/H6) reads 'Antibiotic biosynthesis.' These annotations are backed by experimental evidence (ECO:0000269) from three PubMed references describing in vitro enzymatic characterization and in vivo gene cluster analysis. The sequence matches the benchmark exactly (SHA-256 confirmed).

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H5](#evidence-h5), [H6](#evidence-h6), [H7](#evidence-h7), [C4](#evidence-c4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the conserved P450 heme-binding motif (FGYGVHQCLG...Cys), identifying it as a cytochrome P450 monooxygenase. P450s catalyze oxidative modifications (epoxidation, hydroxylation) of organic substrates. Among the four options: (C) protein quality control requires chaperones/proteases/ubiquitin machinery — incompatible with a P450; (B) killing of cells of another organism implies direct cytotoxic action (e.g., bacteriocins, pore-forming toxins) — a monooxygenase does not directly kill cells; (D) response to antibiotic implies resistance mechanisms such as efflux pumps, drug-modifying transferases (acetyltransferases, phosphotransferases), or target-site mutations — P450s are not canonical resistance enzymes. (A) antibiotic biosynthetic process fits because P450s in actinomycete secondary-metabolite gene clusters perform post-PKS tailoring (epoxidation, hydroxylation) of polyketide intermediates, which is the defining role of biosynthetic P450s in natural-product pathways.


**Missing item-specific fact**

> The organism name (Streptomyces) is not provided in the input, and the specific substrate (macrolide intermediate FD-892) is not stated. However, the P450 identification from the heme-binding motif plus general knowledge that P450s in secondary-metabolite contexts perform biosynthetic tailoring (rather than resistance or protein-quality-control roles) provides a defensible reasoning chain to option A.


**Reason**

> A model can identify the protein as a P450 from the conserved Cys-containing heme-binding motif visible in the sequence, then apply general biological knowledge: P450s are oxidative tailoring enzymes in natural-product biosynthesis, not protein-quality-control factors (C), not direct cell-killing agents (B), and not typical antibiotic-resistance enzymes (D). This leaves antibiotic biosynthetic process (A) as the best-fitting GO term. The reasoning relies on general P450 biochemistry and the known roles of P450s in secondary metabolism rather than memorizing a specific database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options B and C are clearly incompatible with P450 monooxygenase enzymology. Option D (response to antibiotic) describes resistance/sensitivity responses, which involve efflux, transferases, or target modification — not P450-mediated oxidative tailoring. Option A is the only choice consistent with a P450 performing regioselective epoxidation/hydroxylation of a natural-product intermediate. No other option is defensible for this enzyme class.


### Important caveats

- The organism (Streptomyces halstedii) is not stated in the model input; the reasoning relies on recognizing the P450 fold and applying general knowledge about P450 roles in secondary metabolism.
- The GO annotation GO:0017000 in UniProt carries an IEA:UniProtKB-KW evidence code (keyword-based inference), though the underlying functional characterization is experimentally supported (ECO:0000269).
- The benchmark sequence matches the current and historical (v48) UniProt entry exactly (SHA-256 confirmed).
- Without the organism context, a model must rely on P450 motif recognition and general knowledge that P450s in natural-product pathways are biosynthetic rather than resistance enzymes — this is standard biochemistry but adds a layer of inference beyond pure sequence reading.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the conserved P450 heme-binding motif (FGYGVHQCLG...Cys), identifying it as a cytochrome P450 monooxygenase. P450s catalyze oxidative modifications (epoxidation, hydroxylation) of organic substrates. Among the four options: (C) protein quality control requires chaperones/proteases/ubiquitin machinery — incompatible with a P450; (B) killing of cells of another organism implies direct cytotoxic action (e.g., bacteriocins, pore-forming toxins) — a monooxygenase does not directly kill cells; (D) response to antibiotic implies resistance mechanisms such as efflux pumps, drug-modifying transferases (acetyltransferases, phosphotransferases), or target-site mutations — P450s are not canonical resistance enzymes. (A) antibiotic biosynthetic process fits because P450s in actinomycete secondary-metabolite gene clusters perform post-PKS tailoring (epoxidation, hydroxylation) of polyketide intermediates, which is the defining role of biosynthetic P450s in natural-product pathways.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The organism name (Streptomyces) is not provided in the input, and the specific substrate (macrolide intermediate FD-892) is not stated. However, the P450 identification from the heme-binding motif plus general knowledge that P450s in secondary-metabolite contexts perform biosynthetic tailoring (rather than resistance or protein-quality-control roles) provides a defensible reasoning chain to option A.",
    "reason": "A model can identify the protein as a P450 from the conserved Cys-containing heme-binding motif visible in the sequence, then apply general biological knowledge: P450s are oxidative tailoring enzymes in natural-product biosynthesis, not protein-quality-control factors (C), not direct cell-killing agents (B), and not typical antibiotic-resistance enzymes (D). This leaves antibiotic biosynthetic process (A) as the best-fitting GO term. The reasoning relies on general P450 biochemistry and the known roles of P450s in secondary metabolism rather than memorizing a specific database entry."
  },
  "case_id": "GO_biological_process_0121",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H5",
      "H6",
      "H7",
      "C4"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry E0D207 (Cytochrome P450 GfsF from Streptomyces halstedii) is explicitly annotated with GO:0017000 'antibiotic biosynthetic process' (H7). The FUNCTION comment (C5/H5) states it is 'Involved in the synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892,' and the PATHWAY comment (C6/H6) reads 'Antibiotic biosynthesis.' These annotations are backed by experimental evidence (ECO:0000269) from three PubMed references describing in vitro enzymatic characterization and in vivo gene cluster analysis. The sequence matches the benchmark exactly (SHA-256 confirmed)."
  },
  "important_caveats": [
    "The organism (Streptomyces halstedii) is not stated in the model input; the reasoning relies on recognizing the P450 fold and applying general knowledge about P450 roles in secondary metabolism.",
    "The GO annotation GO:0017000 in UniProt carries an IEA:UniProtKB-KW evidence code (keyword-based inference), though the underlying functional characterization is experimentally supported (ECO:0000269).",
    "The benchmark sequence matches the current and historical (v48) UniProt entry exactly (SHA-256 confirmed).",
    "Without the organism context, a model must rely on P450 motif recognition and general knowledge that P450s in natural-product pathways are biosynthetic rather than resistance enzymes — this is standard biochemistry but adds a layer of inference beyond pure sequence reading."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options B and C are clearly incompatible with P450 monooxygenase enzymology. Option D (response to antibiotic) describes resistance/sensitivity responses, which involve efflux, transferases, or target modification — not P450-mediated oxidative tailoring. Option A is the only choice consistent with a P450 performing regioselective epoxidation/hydroxylation of a natural-product intermediate. No other option is defensible for this enzyme class."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0121",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry E0D207 (Cytochrome P450 GfsF from Streptomyces halstedii) is explicitly annotated with GO:0017000 'antibiotic biosynthetic process' (H7). The FUNCTION comment (C5/H5) states it is 'Involved in the synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892,' and the PATHWAY comment (C6/H6) reads 'Antibiotic biosynthesis.' These annotations are backed by experimental evidence (ECO:0000269) from three PubMed references describing in vitro enzymatic characterization and in vivo gene cluster analysis. The sequence matches the benchmark exactly (SHA-256 confirmed).",
    "evidence_ids": ["C5", "C6", "H5", "H6", "H7", "C4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the conserved P450 heme-binding motif (FGYGVHQCLG...Cys), identifying it as a cytochrome P450 monooxygenase. P450s catalyze oxidative modifications (epoxidation, hydroxylation) of organic substrates. Among the four options: (C) protein quality control requires chaperones/proteases/ubiquitin machinery — incompatible with a P450; (B) killing of cells of another organism implies direct cytotoxic action (e.g., bacteriocins, pore-forming toxins) — a monooxygenase does not directly kill cells; (D) response to antibiotic implies resistance mechanisms such as efflux pumps, drug-modifying transferases (acetyltransferases, phosphotransferases), or target-site mutations — P450s are not canonical resistance enzymes. (A) antibiotic biosynthetic process fits because P450s in actinomycete secondary-metabolite gene clusters perform post-PKS tailoring (epoxidation, hydroxylation) of polyketide intermediates, which is the defining role of biosynthetic P450s in natural-product pathways.",
    "missing_item_specific_fact": "The organism name (Streptomyces) is not provided in the input, and the specific substrate (macrolide intermediate FD-892) is not stated. However, the P450 identification from the heme-binding motif plus general knowledge that P450s in secondary-metabolite contexts perform biosynthetic tailoring (rather than resistance or protein-quality-control roles) provides a defensible reasoning chain to option A.",
    "reason": "A model can identify the protein as a P450 from the conserved Cys-containing heme-binding motif visible in the sequence, then apply general biological knowledge: P450s are oxidative tailoring enzymes in natural-product biosynthesis, not protein-quality-control factors (C), not direct cell-killing agents (B), and not typical antibiotic-resistance enzymes (D). This leaves antibiotic biosynthetic process (A) as the best-fitting GO term. The reasoning relies on general P450 biochemistry and the known roles of P450s in secondary metabolism rather than memorizing a specific database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options B and C are clearly incompatible with P450 monooxygenase enzymology. Option D (response to antibiotic) describes resistance/sensitivity responses, which involve efflux, transferases, or target modification — not P450-mediated oxidative tailoring. Option A is the only choice consistent with a P450 performing regioselective epoxidation/hydroxylation of a natural-product intermediate. No other option is defensible for this enzyme class."
  },
  "important_caveats": [
    "The organism (Streptomyces halstedii) is not stated in the model input; the reasoning relies on recognizing the P450 fold and applying general knowledge about P450 roles in secondary metabolism.",
    "The GO annotation GO:0017000 in UniProt carries an IEA:UniProtKB-KW evidence code (keyword-based inference), though the underlying functional characterization is experimentally supported (ECO:0000269).",
    "The benchmark sequence matches the current and historical (v48) UniProt entry exactly (SHA-256 confirmed).",
    "Without the organism context, a model must rely on P450 motif recognition and general knowledge that P450s in natural-product pathways are biosynthetic rather than resistance enzymes — this is standard biochemistry but adds a layer of inference beyond pure sequence reading."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `E0D207` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 48. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D207.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:54.759416+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"20589823","source":"PubMed"}],"value":"P450 monooxygenase GfsF"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"20589823","source":"PubMed"}],"value":"1.14.-.-"}],"fullName":{"value":"Cytochrome P450 GfsF"}}}
```

Source SHA-256: `dc5a5ddf81c1b51af907306ca972dbc709d4db40c846bfe03ce3ae8bd6cb3e37`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D207.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:54.759416+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"20589823","source":"PubMed"},{"evidenceCode":"ECO:0000269","id":"26630077","source":"PubMed"},{"evidenceCode":"ECO:0000269","id":"28869713","source":"PubMed"}],"value":"Involved in the synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892 (PubMed:20589823, PubMed:26630077, PubMed:28869713). Consecutively catalyzes epoxidation of C8-C9 and then hydroxylation at C10 to convert 25-O-methyl-FD-892 to FD-891 (PubMed:20589823). Consecutively catalyzes epoxidation of C8-C9 and then hydroxylation at C10 to convert 8,9-epoxy-FD-892 to 25-O-demethyl-FD-891 as well as converting 25-oxo-FD-892 to 8,9-epoxy-25-oxo-FD-892 and 8,9-epoxy-10-hydroxy-25-oxo-FD-892 (PubMed:26630077). In vitro is furnished with P.putida putidaredoxin and putidaredoxin reductase to provide the required two-electron reduction (PubMed:20589823, PubMed:26630077, PubMed:28869713)"}]}
```

Source SHA-256: `dc5a5ddf81c1b51af907306ca972dbc709d4db40c846bfe03ce3ae8bd6cb3e37`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D207.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:54.759416+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"20589823","source":"PubMed"},{"evidenceCode":"ECO:0000269","id":"26630077","source":"PubMed"}],"value":"Antibiotic biosynthesis"}]}
```

Source SHA-256: `dc5a5ddf81c1b51af907306ca972dbc709d4db40c846bfe03ce3ae8bd6cb3e37`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D207?format=txt&versions=48)  
**Locator:** `lines 63-74`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 48 / 1.  
**Retrieved:** 2026-11-02T04:27:56.758195+00:00.  

```text
CC   -!- FUNCTION: Involved in the synthesis of the 16-membered macrolide
CC       antibiotics FD-891 and FD-892 (PubMed:20589823, PubMed:26630077,
CC       PubMed:28869713). Consecutively catalyzes epoxidation of C8-C9 and then
CC       hydroxylation at C10 to convert 25-O-methyl-FD-892 to FD-891
CC       (PubMed:20589823). Consecutively catalyzes epoxidation of C8-C9 and
CC       then hydroxylation at C10 to convert 8,9-epoxy-FD-892 to 25-O-demethyl-
CC       FD-891 as well as converting 25-oxo-FD-892 to 8,9-epoxy-25-oxo-FD-892
CC       and 8,9-epoxy-10-hydroxy-25-oxo-FD-892 (PubMed:26630077). In vitro is
CC       furnished with P.putida putidaredoxin and putidaredoxin reductase to
CC       provide the required two-electron reduction (PubMed:20589823,
CC       PubMed:26630077, PubMed:28869713). {ECO:0000269|PubMed:20589823,
CC       ECO:0000269|PubMed:26630077, ECO:0000269|PubMed:28869713}.
```

Source SHA-256: `b7ff243274350eac91391be3b79c5530cd2a2ec42701fd8dc7b36bcbeb0f7237`.

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D207?format=txt&versions=48)  
**Locator:** `lines 78-79`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 48 / 1.  
**Retrieved:** 2026-11-02T04:27:56.758195+00:00.  

```text
CC   -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000269|PubMed:20589823,
CC       ECO:0000269|PubMed:26630077}.
```

Source SHA-256: `b7ff243274350eac91391be3b79c5530cd2a2ec42701fd8dc7b36bcbeb0f7237`.

### Evidence H7

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D207?format=txt&versions=48)  
**Locator:** `lines 107-107`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 48 / 1.  
**Retrieved:** 2026-11-02T04:27:56.758195+00:00.  

```text
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
```

Source SHA-256: `b7ff243274350eac91391be3b79c5530cd2a2ec42701fd8dc7b36bcbeb0f7237`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 121. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
